Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Neuropsychiatric symptoms and the APOE genotype in Alzheimer's disease.

Del Prete M, Spaccavento S, Craca A, Fiore P, Angelelli P.

Neurol Sci. 2009 Oct;30(5):367-73. doi: 10.1007/s10072-009-0116-9. Epub 2009 Jul 10.

PMID:
19590821
2.

Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer's disease.

Hollingworth P, Hamshere ML, Moskvina V, Dowzell K, Moore PJ, Foy C, Archer N, Lynch A, Lovestone S, Brayne C, Rubinsztein DC, Lawlor B, Gill M, Owen MJ, Williams J.

J Am Geriatr Soc. 2006 Sep;54(9):1348-54.

PMID:
16970641
3.

Contrasts Between Patients With Lewy Body Dementia Syndromes and APOE-ε3/ε3 Patients With Late-onset Alzheimer Disease Dementia.

Oliveira FF, Machado FC, Sampaio G, Marin SM, Chen ES, Smith MC, Bertolucci PH.

Neurologist. 2015 Aug;20(2):35-41. doi: 10.1097/NRL.0000000000000045.

PMID:
26280289
4.
5.

Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease.

Panza F, Frisardi V, Seripa D, D'Onofrio G, Santamato A, Masullo C, Logroscino G, Solfrizzi V, Pilotto A.

Ageing Res Rev. 2012 Jan;11(1):87-103. doi: 10.1016/j.arr.2011.06.005. Epub 2011 Jul 7. Review.

PMID:
21763789
6.

Apolipoprotein epsilon 4 allele and disease progression in patients with late-onset Alzheimer's disease.

Basun H, Grut M, Winblad B, Lannfelt L.

Neurosci Lett. 1995 Jan 2;183(1-2):32-4.

PMID:
7746480
7.

Associations of cerebrovascular metabolism genotypes with neuropsychiatric symptoms and age at onset of Alzheimer's disease dementia.

Oliveira FF, Chen ES, Smith MC, Bertolucci PH.

Braz J Psychiatry. 2017 Apr-Jun;39(2):95-103. doi: 10.1590/1516-4446-2016-1991. Epub 2017 Jan 12.

8.

Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.

Kleiman T, Zdanys K, Black B, Rightmer T, Grey M, Garman K, Macavoy M, Gelernter J, van Dyck C.

Dement Geriatr Cogn Disord. 2006;22(1):73-82. Epub 2006 May 12.

9.

Lack of effect of apolipoprotein E E4 allele on neuropsychiatric manifestations in Alzheimer's disease.

Hirono N, Mori E, Yasuda M, Imamura T, Shimomura T, Hashimoto M, Tanimukai S, Kazui H, Yamashita H.

J Neuropsychiatry Clin Neurosci. 1999 Winter;11(1):66-70.

PMID:
9990558
10.

Butyrylcholinesterase K and apolipoprotein ε4 affect cortical thickness and neuropsychiatric symptoms in Alzheimer's disease.

Yoo HB, Lee HW, Shin S, Park SW, Choi JS, Jung HY, Cha J, Lee JM, Lee JY.

Curr Alzheimer Res. 2014 Feb;11(2):137-44.

PMID:
24479631
11.

Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease.

Dal Forno G, Rasmusson DX, Brandt J, Carson KA, Brookmeyer R, Troncoso J, Kawas CH.

Arch Neurol. 1996 Apr;53(4):345-50.

PMID:
8929157
12.

Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease.

Levy ML, Cummings JL, Fairbanks LA, Sultzer DL, Small GW.

Biol Psychiatry. 1999 Feb 15;45(4):422-5.

PMID:
10071711
13.

Depression, delusions, and hallucinations in Alzheimer's disease: no relationship to apolipoprotein E genotype.

Lyketsos CG, Baker L, Warren A, Steele C, Brandt J, Steinberg M, Kopunek S, Baker A.

J Neuropsychiatry Clin Neurosci. 1997 Winter;9(1):64-7.

PMID:
9017530
14.

The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes.

D'Onofrio G, Panza F, Seripa D, Sancarlo D, Paris F, Cascavilla L, Urbano M, Gravina C, Fontana A, Solfrizzi V, Pellegrini F, Pilotto A.

Int J Geriatr Psychiatry. 2011 Oct;26(10):1062-70. doi: 10.1002/gps.2644. Epub 2010 Oct 29.

PMID:
21905100
15.

Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.

Marra C, Bizzarro A, Daniele A, De Luca L, Ferraccioli M, Valenza A, Brahe C, Tiziano FD, Gainotti G, Masullo C.

Dement Geriatr Cogn Disord. 2004;18(2):125-31. Epub 2004 Jun 18.

PMID:
15211066
16.

Apolipoprotein E: depressive illness, depressive symptoms, and Alzheimer's disease.

Holmes C, Russ C, Kirov G, Aitchison KJ, Powell JF, Collier DA, Lovestone S.

Biol Psychiatry. 1998 Feb 1;43(3):159-64.

PMID:
9494696
17.
18.

Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.

Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R.

Arch Neurol. 2005 Jun;62(6):975-80.

PMID:
15956169
19.

Prevalence of neuropsychiatric symptoms in young-onset compared to late-onset Alzheimer's disease - part 1: findings of the two-year longitudinal NeedYD-study.

van Vliet D, de Vugt ME, Aalten P, Bakker C, Pijnenburg YA, Vernooij-Dassen MJ, Koopmans RT, Verhey FR.

Dement Geriatr Cogn Disord. 2012;34(5-6):319-27. doi: 10.1159/000342824. Epub 2012 Dec 3.

PMID:
23208452
20.

Apolipoprotein E ε4 status modifies the effects of sex hormones on neuropsychiatric symptoms of Alzheimer's disease.

Xing Y, Qin W, Li F, Jia XF, Jia J.

Dement Geriatr Cogn Disord. 2012;33(1):35-42. doi: 10.1159/000336600. Epub 2012 Mar 2.

PMID:
22398564

Supplemental Content

Support Center